Showing results (31-40 of 105) with videos related to
Sort By:
Pageof 11
Science Translational Medicine|March 31, 2012
Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escapeJanis M Taube, Robert A Anders, Geoffrey D Young, et al.Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapyFlorence R Depontieu, Jie Qian, Angela L Zarling, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced MelanomaJeffrey S Weber, F Stephen Hodi, Jedd D Wolchok, et al.Journal for Immunotherapy of Cancer|November 29, 2018
Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapyNatalie J Miller, Candice D Church, Steven P Fling, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitisJames C Yang, Marybeth Hughes, Udai Kammula, et al.Journal for Immunotherapy of Cancer|November 21, 2024
Immune microenvironment of Epstein-Barr virus (EBV)-negative compared to EBV-associated gastric cancers: implications for immunotherapyTracee L McMiller, Sepideh Besharati, Mark Yarchoan, et al.Journal for Immunotherapy of Cancer|June 23, 2016
Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common ruleHoward L Kaufman, Lisa H Butterfield, Pierre G Coulie, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanomaSteven A Rosenberg, James C Yang, Paul F Robbins, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 11, 2013
Structure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicityShuming Chen, Yili Li, Florence R Depontieu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancerJoseph A Blansfield, Kimberly E Beck, Khoi Tran, et al.Pageof 11